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Case Report Rapport de cas
Osteomyelitis associated with Nocardiopsis composta in a dog
Elisa N. Salas, Debra Royal, Lance Kurz, J. Dustin Loy
Abstract — We report the first detection of Nocardiopsis composta in association with osteomyelitis in a young 
male miniature Australian shepherd dog. Findings included suppurative osteomyelitis containing intralesional 
Fite’s acid fast bacilli, aerobic culture of branching Gram-positive rods, and positive identification via phenotypic 
analysis and 16S rDNA sequencing.
Résumé — Ostéomyélite associée à Nocardiopsis composta chez un chien. Nous signalons la première détection 
de Nocardiopsis composta en association avec l’ostéomyélite chez un jeune chien berger Australien miniature mâle. 
Les résultats incluaient une ostéomyélite suppurative contenant des bacilles alcoolo-acido résistants à la coloration 
de Fite, une culture aérobie de bâtonnets à Gram positif embranchés et l’identification positive par une analyse 
phénotypique et le séquençage de l’ADNr 16S.
(Traduit par Isabelle Vallières)
Can Vet J 2015;56:466–470
O steomyelitis can be caused by bacterial or fungal agents or may be idiopathic. Cocci, bacilli, and filamentous 
bacteria such as members of the Actinomycetes have all been 
determined to be causes of osteomyelitis. Differential diagnoses 
for Gram-positive filamentous rods in the family Actinomycetales 
causing osteomyelitis in the dog, include members of the more 
frequently encountered genera Nocardia and Actinomyces (1,2). 
Bacteria gain access to the bone via several routes, but are most 
often associated with direct inoculation (such as percutaneous 
injuries, compound fractures, or secondary to foreign bodies 
such as surgical or other material including dirt and wood) 
and fracture instability. Less frequently, the route is hematog-
enous, as has been found with Propionibacterium acnes (3). 
Agents isolated from osteolytic lesions in dogs and cats have 
included Gram-positive Staphylococcus spp., Streptococcus spp., 
Gram-negative Escherichia coli, Proteus spp., Klebsiella spp., 
Pseudomonas spp., anaerobic Clostridium spp., Peptostreptococcus 
spp., Actinomyces spp., Bacterioides spp., Fusobacterium spp., and 
rarely Brucella canis, Nocardia spp., and Mycobacterium avium 
(3,4). Fungal causes include Coccidioides immitis, Blastomyces 
dermatitidis, Histoplasma capsulatum, Cryptococcus neoformans, 
and Aspergillus spp. (3). Osteosarcoma with associated cellulitis 
is a reported noninfectious cause of osteomyelitis in dogs (5). 
Our report details the diagnosis, treatment, and resolution of 
osteomyelitis in a dog caused by a unique agent, Nocardiopsis 
composta.
Case description
A 1-year-old neutered male miniature Australian shepherd dog 
was presented to a primary care veterinarian with a 6-week his-
tory of right hind limb weight-bearing lameness. Upon physical 
examination, a hard, 2-cm diameter mass was palpated at the 
medial right tibia. Radiographs revealed an osteolytic lesion 
in the mid-diaphysis of the limb (Figure 1). A 4-mm punch 
bone biopsy was taken 3 wk following initial examination and 
was submitted in 10% buffered formalin, decalcified in 12% 
hydrochloric acid for 4 h, processed, sectioned, and stained with 
hematoxylin and eosin (H & E). Histologic sections revealed 
moderate numbers of intact and degenerate neutrophils in the 
inter-trabecular spaces admixed with moderately abundant 
fibrin, mild amounts of karyorrhectic and cytolytic cellular 
debris, and few pyknotic nuclei. Osteolysis was characterized 
by disruption of boney trabeculae and replacement by fibrin 
and fibrosis. Few, multifocal, and prominent Howship’s lacunae 
were present (osteoclastic resorption) (Figure 2A). Brown and 
Brenn Gram stain and Gomori’s methanamine silver stain on 
histologic sections failed to reveal a bacterial or fungal etiol-
ogy, respectively. However, due to the presence of neutrophils, 
radiographic findings of osteomyelitis, and age of the patient, 
an infectious, rather than neoplastic, etiology was suspected. 
Following culture results from a subsequent biopsy, a Fite’s 
acid fast stain was conducted retrospectively on the initial 
fixed paraffin-embedded biopsy and revealed small numbers of 
intralesional, acid fast positive, branching bacilli approximately 
3 mm 3 1 mm in size (Figure 2B). Empirical antimicrobial 
treatment was initiated, as fresh tissues were not initially col-
lected for culture. After 4 wk of therapy with amoxicillin and 
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Figure 1. A — Dorsoventral radiograph of the rear limbs. A 
midshaft area of radiolucency consistent with boney lysis is seen 
in the right tibia. The left tibia is normal. B — Left to right lateral 
view of the left tibia. The area of lucency is oval and is bordered 
by mild boney proliferation.
A
B
Figure 2. Punch biopsy of bone. A — Moderate numbers of 
neutrophils fill the intertrabecular spaces of lamellar bone. 
A small focus of osteolysis is present (asterisk) (Hematoxylin 
and eosin, Bar = 50 mm). B — Few, small, extracellular, 1 mm 3 
3 mm, Fite’s acid-fast positive, branching bacilli are seen within 
intertrabecular spaces. (Fite’s acid fast stain, Bar = 10 mm)
A
B
50 mm
10 mm
Figure 3. Gram-stained heat-fixed colony smear showing Gram-
positive branching rods. (Bar = 10 mm)
10 mm
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clavulanate, radiolucency consistent with osteomyelitis of the 
right tibia was still apparent and clinical lameness persisted. We 
therefore initiated therapy with clindamycin.
Five months following cessation of antimicrobial treatment, 
lameness and radiographic osteolysis were still noted. A fresh, 
non-fixed, bone biopsy was taken and submitted for culture and 
identification of an etiologic agent. A branching Gram-positive 
bacillus was observed on Gram-stained colony smears (Figure 3) 
and was subsequently isolated in pure growth on tryptic soy agar 
with 5% sheep’s blood following 72 h incubation at 37°C in an 
atmosphere of 5% CO2. This organism was sent to a laboratory 
(Accugenix; Newark, Delaware, USA) where a 480 nucleotide 
amplic on of the 16S rDNA was amplified and sequenced. 
Analysis (NCBI BLASTn) of the DNA sequence showed 99.6% 
nucleotide identity to Nocardiopsis composta reference strain KS9 
(NR_025152.1). This was sufficient to determine identification 
to the genus and species level according to Clinical Laboratory 
Standards Institute (CLSI) approved interpretive criteria for 
16S sequencing of aerobic actinomycetes (6,7). Antimicrobial 
susceptibility testing was conducted using the Kirby-Bauer disc 
diffusion susceptibility test based on modification of methods 
from the CLSI (8). These included the use of Müeller-Hinton 
agar and an extended incubation time of 72 h. Zones of growth 
inhibition were measured using a BioMIC instrument (BioMIC 
Giles Scientific, Santa Barbara, California, USA). Recognizing 
that validated antimicrobial susceptibility testing methodology 
and specific interpretive criteria for this organism do not exist, 
susceptibility breakpoints for zones of inhibition in mm were 
based on CLSI guidelines for Gram-positive veterinary isolates 
where available (8). Zones of inhibition for specific antimicrobi-
als are presented in Table 1. The isolate of Nocardiopsis composta 
appeared resistant to most drugs tested, including clindamycin 
and erythromycin, but was susceptible in vitro to ceftiofur, 
trimethoprim-sulfamethoxazole, and vancomycin.
A 60-day empirical therapy with clarithromycin had been 
initiated prior to identification of the etiologic agent. Clinical 
examination and radiographs taken at a 2-month follow-up 
examination indicated further progression of the osteolysis. 
The patient was then placed on high-dose trimethoprim/ 
sulfamethoxazole for 21 d. Therapy was discontinued following 
elevation of blood urea nitrogen (17.5 mmol/L, reference range: 
2.5 to 9.6 mmol/L) due to concern regarding potential antibi-
otic toxicosis. A follow-up examination 8 mo after cessation of 
antibiotics indicated a resolution of both the presenting clinical 
signs and radiographic boney lysis with probable clearance of 
the organism.
Discussion
The genus Nocardiopsis in the order Actinomycetales contains 
aerobic actinomycetes and was proposed by Meyer based on 
morphological and biochemical analyses (9). Although related, 
these organisms are a distinct genus from the more commonly 
identified genus Nocardia. The genus Norcardiopsis was sepa-
rated from the genus Actinomadura, and originally represented 
actinomycetes with substrate mycelium that fragments into 
coccoid elements and has a specific cell wall composition of 
meso-2,6-diaminopimelic acid that contains no diagnostically 
useful sugars. The genus Nocardiopsis has since been refined, 
based on additional chemotaxonomic analysis, and was revised 
to include only organisms with a fatty acid composition of 
type 3d and DNA G 1 C content of 64 to 71 molar percent 
(10). Nocardiopsis composta was initially isolated from the 
atmosphere of a composting facility in Germany and is one of 
41 validly named species or subspecies within the genus (11,12).
To our knowledge, this is the first report of isolation of 
Nocardiopsis composta in association with a pathologic process in 
any animal species. Another member of the genus, Nocardiopsis 
alba, was recently identified in association with a case of 
chronic laminitis in a horse, the only report found of a closely 
related species in animals (13). Other members of the genus 
Nocardiopsis have been rarely documented to cause infections in 
humans, and nearly all of these have been attributed to a single 
species, Nocadiopsis dassonvelli. Nocardiopsis dassonvelli has been 
isolated in association with human diseases that include cutane-
ous infection, cellulitis, actinomycetoma, respiratory infection, 
nasal vestibulitis, blood cultures of a child with respiratory dis-
tress and a man with cholangitis (14–22). Although the preva-
lence of these infections in human medicine is poorly under-
stood, one report indicates that the Centers for Disease Control 
identified 21 isolates as N. dassonvelli between 1981 and 1986 
Table 1. Kirby-Bauer antimicrobial susceptibility results for Nocardiopsis composta 
isolate.
Antimicrobial IC mma Antimicrobial IC mm
Ceftiofur S 30 Tetracycline I 15
Ceftriaxone NI 26 Penicillin G R 13
Clindamycin R  6 Spectinomycin R  6
Ciprofloxacin NI 20 Tiamulin R  6
Danofloxacin I 21 Tilmicosin R  6
Enrofloxacin I 22 Tobramycin NI 14
Erythromycin R  6 Trimethoprim- S 41 
   sulfamethoxazole
Florfenicol R  8 Tulathromycin R  6
Orbifloxacin R 13 Vancomycin S 29
a Interpretive criteria (IC) of zones of inhibition (mm) using susceptible (S), intermediate (I), or resistant 
(R) were taken from gram positive rod category, where available (8). NI indicates no interpretive criteria 
exist.
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(23). In many cases described in the literature, patients suffered 
from protracted disease. In 8 patients described in case reports, 
1 had treatment with corticosteroids prior to presentation and 
another was concurrently diabetic (15,19). Two patients with 
cellulitis had reported previous trauma, presumably allowing 
for a decrease in localized cutaneous defenses (18,20). Thus, 
immunosuppressive conditions could play a role in pathogenesis 
of infections with organisms of this genus (18,20).
The human patients affected by cutaneous infection, subcu-
taneous infection, and nasal vestibulitis lacked osteomyeletis. 
When performed, histopathologic examination in human 
cases revealed a suppurative to pyogranulomatous infection 
with intralesional Gram-positive, periodic acid-Schiff nega-
tive, and modified acid-fast negative filamentous branching 
bacilli (15,18,20). In our case, initial histologic examination of 
H & E stained sections failed to reveal visible bacilli. However 
subsequent Fite’s acid fast staining revealed branching acid fast 
bacilli. Peanut oil used in Fite’s acid fast stain has been shown 
to enhance penetration of the stain in waxy tissue or bacterial 
cell walls (24). Thus, it is recommended using this stain over 
traditional modified acid fast stains if Nocardiopsis is suspected.
In human cases of Nocardiopsis dassonvelli, therapies that 
resulted in resolution of clinical signs included oral trimethoprim /
sulfamethoxazole, combination oral therapy of trimethoprim 
and gentamicin, intravenous piperacillin and ciprofloxacin, 
trimethoprim/ sulfamethoxazole in conjunction with clarithromy-
cin and levofloxacin, and minomycin (14–16,18–20,25). Based 
on the antimicrobial susceptibility test results which showed 
resistance to clarithromycin, the patient was then treated with 
high dose trimethoprim/sulfamethoxazole with complete resolu-
tion of clinical signs after a 3-week course of treatment. This 
patient had no concurrent immunosuppressive conditions and 
it remains unclear how this organism was introduced into the 
bone. However, trimethoprim/ sulfamethoxazole therapy may be 
a reasonable selection for treatment of osteomyelitis caused by 
Nocardiopsis, due to in vitro susceptibility of the isolate, efficacy 
against related organisms, the spectrum of activity, good absorp-
tion, and a high calculated volume of distribution throughout 
the body tissues (26,27). In the absence of official antimicrobial 
testing methodologies and interpretative data for this particular 
organism, the Kirby-Bauer disc diffusion susceptibility test results, 
although not validated, were utilized in a comparative manner to 
guide the successful antimicrobial therapy of this case of osteo-
myelitis caused by N. composta. Determination of the minimum 
inhibitory concentration would be more appropriate, but the 
methodology is not available in all diagnostic laboratories. This, 
combined with a paucity of published information regarding 
in vitro susceptibilities of these organisms and lack of specific 
interpretive criteria for in vitro antimicrobial susceptibility tests, 
makes comparison of therapy protocols challenging.
We conclude that nonresponsive cases of osteomyelitis war-
rant additional diagnostics and an index of suspicion for more 
fastidious organisms. Testing should include fresh and fixed 
biopsy, Gram stain, Fite’s acid fast stain for optimal penetra-
tion into bacterial cell walls, aerobic culture for a minimum of 
3 d, anaerobic culture, and 16S ribosomal DNA sequencing. 
Treatment should be guided by susceptibility testing using 
approved CLSI protocols when available (8). In light of our 
findings, Nocardiopsis composta should be considered along 
with other etiologies as a possible differential for osteomyelitis 
in animal patients.
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